drugset / Trial / NCT01111981

Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia

NCT01111981

Phase 4 Unknown 30 enrolled Callender Center for Clinical Research
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to ascertain the safety and efficacy of Clobetasol Propionate 0.05% E Foam in the treatment of Central Centrifugal Cicatricial Alopecia.

Timeline

Start
2009-10
Primary completion
2010-02
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject clobetasol propionate Small molecule 0.05 % Topical

Indications